Related Experiment Video

Updated: Oct 5, 2025

Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models
03:38

Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models

Published on: June 20, 2025

413

Diethylcarbamazine as potential treatment of COVID-19 lung fibrosis

Carlos Eduardo Medina-De la Garza1,2, Armando Salvador Flores-Torres1, Marisela García-Hernández1,3

  • 1Immunomodulation Unit, Center for Research and Development in Health Sciences (CIDICS), Universidad Autónoma de Nuevo León, Monterrey, Mexico.

Medical Hypotheses
|January 31, 2022
PubMed

Keywords:
COVID-19-related pulmonary fibrosisDiethylcarbamazineDrug repurposingPost-COVID-19Pulmonary fibrosis

More Related Videos

Artificial Lung Device Priming for In Situ Fiber Bundle Surface Grafting08:53

Artificial Lung Device Priming for In Situ Fiber Bundle Surface Grafting

Published on: March 28, 2025

531
Establishing a Silicosis Rat Model via Exposure of Whole-Body to Respirable Silica05:03

Establishing a Silicosis Rat Model via Exposure of Whole-Body to Respirable Silica

Published on: October 28, 2022

1.4K

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
455